Sensitization of adenylyl cyclase (AC) by increased expression of large isoforms of the stimulatory G-protein G␣ s has been suggested as a mechanism that governs uterine quiescence during pregnancy. We quantified several components of the AC pathway in pregnant (P, n‫)12؍‬ and nonpregnant human myometria (NP, n‫.)01؍‬ AC activity was ϳsev-enfold higher in P than in NP under basal and stimulated conditions (MnCl 2 /GTP/GTP ؉ isoproterenol). In addition, relative stimulation (% of basal) by 5-guanosine-␤␥-iminotriphosphate and forskolin was twofold higher in P. ␤-Adrenoceptor density was low and unaltered in P. G␣ s mRNA splice variants did not differ in P. Using antisera against different epitopes of G␣ s (carboxyl-/more aminoterminal), we found unchanged expression of G␣ s short and long (45, 47 kDa) in P. Two additional proteins in P (51, 59 kDa) were detectable only by the carboxyl-terminal antiserum and lacked GTP binding properties. The 59 kDa protein could be identified as a recently discovered cytoskeletal protein, smoothelin, which was 10-fold increased in P. These data indicate that the apparent up-regulation of large G␣ s species in P is mimicked by elevated smoothelin. Therefore, the increase in AC cannot be attributed to changes in G␣ s -or ␤-adrenoreceptors. Epitope sharing between G␣ s and smoothelin should be considered in experiments on smooth muscle tissues.-Gsell, S., Eschenhagen, T., Kaspareit, G., Nose, M., Scholz, H., Behrens, O., Wieland, T. Apparent up-regulation of stimulatory G-protein ␣ subunits in the pregnant human myometrium is mimicked by elevated smoothelin expression. FASEB J. 14, 17-26 (2000)
The balance of uterine quiescence and contractile activity during pregnancy is regulated by several stimulatory and inhibitory pathways. The mechanisms that govern the switch between these opposing functional states are still incompletely understood. About a dozen different receptors and endogenous agonists like peptide hormones, prostanoids, muscarinic and adrenergic receptor agonists, histamine, and others are involved in stimulation of the contractile apparatus. The majority of them induce contractility via activation of phospholipase C (PLC) stimulating the production of the second messengers inositol 1,4,5 -trisphosphate and diacylglycerol (1) (2) (3) .
Adrenergic stimulation can induce both contractility and relaxation. For instance, in rat and human myometrium, stimulation of ␣ 2 -adrenoceptors leads to contraction by inhibition of adenylyl cyclase (AC) through inhibitory G-proteins (4, 5) . Ligand occupation of ␤ 2 -adrenoceptors activates AC via stimulatory G-proteins, increases cAMP and induces relaxation. In rabbit myometria the effect of adrenergic stimulation is modulated by the gonadal steroids estrogen and progesterone. Under estrogen predominance, ␤ 2 -adrenoreceptor-mediated cAMP production and G␣ s levels are reduced and contraction prevails, whereas progesterone-predominance favors relaxation (6) . Similar data have been reported from rat myometrium (7) . In human myometria, G␣ s was found to be increased during pregnancy and downregulated during preterm and term labor, whereas members of the pertussis-sensitive G␣ i family remained unchanged during pregnancy (8, 9) .
The resulting changes in Gs/Gi ratio could explain the change from a relaxed to a contractile phenotype and led to the hypothesis that expression levels of G␣ s may be crucial for myometrial AC 1 Some of the results reported here have been published in abstract form in Naunyn Schmiedebergs Arch. Pharmacol., Vol. 357 (Suppl.), p. R58 (1998) and Vol. 359 (Suppl.), p. R55 (1999). 2 Correspondence: Institute of Experimental and Clinical Pharmacology and Toxicology, Department of Clinical Pharmacology, Friedrich-Alexander-University Erlangen-Nuremberg, Fahrstr. 17, D-91054 Erlangen, Germany. E-mail: thomas.eschenhagen@pharmakologie.uni-erlangen.de activity and thereby for regulation of the onset of labor. The increase in total G␣ s during pregnancy was due exclusively to the appearance of immunoreactive proteins with an apparent molecular mass of 46 and 54 in addition to 45, 47, and 58 kDa bands also detected in nonpregnant tissues. The 46, 54 and 58 kDa proteins, however, failed to be ADP-ribosylated by cholera toxin (8) . The present study was undertaken to follow up on these findings and test whether G␣ s isoforms are indeed up-regulated in human myometrium during pregnancy and whether corresponding alterations in the G␣s mRNA splice variant pattern occur.
MATERIALS AND METHODS

Materials
All chemicals were of analytical or best commercial grade available. Antibody 3A-150 against the extreme carboxyl terminus of G␣ s (AA 385-394 in G␣ s ; RMHLRQYELL) was from Gramsch Laboratories (Schwabhausen, Germany). Antibody K-20 against a more amino-terminal epitope of G␣ s (AA 100 -119; KEAIETIVAAMSNLVPPVE) was from Santa Cruz Biotechnology Inc. (Santa Cruz, Calif.). The mouse monoclonal immunoglobulin G1 antibody (R4A) against smoothelin was a kind gift of Dr. G. van Eys (University of Limburg, Maastricht, NL).
Patients and procurement of tissue
Myometrial biopsies of 21 pregnant women with a gestation age between 27 to 41 wk (x n ϭ37Ϯ3.3) were obtained during Caesarian section. Nonpregnant samples (nϭ10) were taken at hysterectomies performed for benign gynecological disorders (e.g., menorrhagia and dysmenorrhea of premenopausal women) and served as control. The samples were frozen in liquid nitrogen and stored at Ϫ80°C until needed. This investigation had the approval of the research ethic committee of Hamburg.
Crude membrane preparation
Preparation was carried out on ice. About 500 mg frozen tissue was homogenized in 5 ml ice-cold (mM) 600 sucrose/10 imidazol-HCl, pH 7.0 with a Polytron homogenizer five times for 20 s, followed by centrifugation for 30 min at 3000 ϫ g at 4°C in a Beckman JA-20 rotor. The supernatant was mixed 1:2 with (mM) 160 KCl and 20 MOPS (pH 7.4) and centrifuged 1 h at 100,000 ϫ g at 4°C in a Kontron TFT 28.38 rotor. Pellets were resuspended in 300 l membrane buffer (mM: 50 Tris, 5 MgCl 2 , 5 EDTA, 5 EGTA) containing aprotinin 2 g/ml and stored at Ϫ80°C.
Adenylyl cyclase assay
AC activity was determined in crude membranes (20 g ) from individual patients according to Salomon (10) as described previously (11) , with the following modifications: reaction mixture contained (in mM): 0.4 IBMX, (3 Ci/ml; 800 Ci/mmol), 10 creatine phosphate, 0.1 cAMP, 0.1 EGTA, 50 NaCl, 40 Tris, 5 MgCl 2 , 0.1 ATP, 0.2% bovine serum albumin, 0.4 mg/ml creatine kinase, and 0. 
Radioligand binding
The density of ␤-adrenoceptors was determined in crude membranes (200 g) by saturation binding experiments (12.5-3000 pM) with the nonspecific
H-4-(3-t-butylamino-2-hydroxy-propoxy) benzimidazole-2-one, 45.4 Ci/mmol; NEN-DuPont) in the absence and presence of 1 M propranolol, as described previously (13).
5-Nucleotidase activity
5Ј-Nucleotidase activity was determined in crude membranes with a commercially available kit according to the manufacturer's protocol (Sigma Diagnostics, Deisenhofen, Germany). To standardize all other measurements except smoothelin to the plasma membrane content, the ratio of mean 5Ј-nucleotidase activity of all samples in the respective assay and the individual 5Ј-nucleotidase activity was used as an a correction factor and multiplied with the respective individual values of AC, ␤-adrenoceptors, and G␣ s .
Immunoblotting
For determination of G␣ s , crude membrane proteins were resolved on 9% Long Ranger (FMC Bioproducts, Rockland, Minn.) polyacrylamide gels containing 6 M urea (50 g/lane for G␣ s ; 100 g/lane for smoothelin) and electrotransferred onto nitrocellulose membranes (Schleicher/Schuell, Dassel, Germany). Antisera 3A-150 and K-20 were used at 1:75,000 and 1:500, respectively. Anti-smoothelin antibody R4A (14) was used at 1:2.5 (according to personal communication of Dr. van Eys). Membranes were incubated with an alkaline phosphatase-coupled goat anti rabbit IgG (1:2500, Dianova, Hamburg, Germany) and developed with NBT/BCIP (Gibco BRL, Life Technologies, Eggenstein, Germany). Intensity of bands was quantified using Zerodescan (CSP).
Homology screening
Searches for sequence homology were performed through EMBL database (primates library) using FASTA version 3.0t71, November 1996 (15).
Immunoprecipitation
Crude membranes (200 g/sample) were pelleted by centrifugation (10 min at 14,000 ϫ g) and solubilized for 80 min in 60 l RIPA-D buffer (mM: 150 NaCl, 25 Tris/HCl, 4 EDTA, 1 PMSF, 0.1% sodium dodecyl sulfate (SDS), 1% Triton X 100, 0.5% DOC) at 4°C. 110 microliters of RIPA-B buffer (RIPA-D without SDS) was added and the sample was centrifuged at 10,000 ϫ g and 4°C for 10 min. The supernatant was incubated without and with antibodies (3A-150, 1:1,000; K-20, 1:1,000) for 3. 32 P]GTP (6000 Ci/mmol; NEN-DuPont) was lyophilized and then dissolved in 40 l EDAC (30 mg/ml in 0.15 M MES, pH 5.6) and incubated for 10 min at room temperature. 10 l of 4-azidoaniline (Fluka, Buchs, Switzerland; 40 mg/ml in 1,4-dioxane) was added and the reaction was incubated for 3 h at room temperature with continuous shaking. Purification was performed using Waters Oasis HLB extraction cartridges (Waters Corp., Milford, Mass.) and a discontinuous gradient (2.8, 9, 20, and 90%) of solvent B (100 mM triethylamine in ethanol) in solvent A (100 mM triethylamine in water). About 25-30 fractions of 500 l each were collected. Purity was chromatographically controlled in aliquots (200,000 dpm) of each fraction on PEI-cellulose using 1M LiCl as solvent, and exposure to X-ray film for 4 -8 h. Fractions containing purified [␥-
32 P]GTPazido-anilide were lyophilized and dissolved in water, giving a final concentration of 1-2 Ci/l. Photoaffinity labeling of G-proteins was performed as follows: 100 microgram crude membranes were incubated in safe light for 3 min at 30°C in a volume of 50 l containing 29 l membrane buffer B (mM: 0.2 EDTA, 20 MgCl 2 , 60 HEPES, 20 NaCl; pH 7.4), 1l adenosine deaminase (5g/l), and 10 l isoproterenol (60 M). 10 l (1.5 Ci) [␥-
32 P]GTP-azido-anilide was added and the samples were incubated for 10 min at 30°C. Reaction was stopped on ice, followed by centrifugation at 11,600 ϫ g for 5 min at 4°C. The pellets were resuspended in 60 l membrane buffer B containing 2 mM DTT, irradiated with 100 J UV light (254 nm), and centrifuged at 11,600 ϫ g for 5 min at 4°C. The pellets were solubilized in RIPA-D buffer and immunoprecipitated as described above.
Preparation of RNA
Total RNA was extracted with the commercially available kit RNAzol (Biotec Lab., Houston, Tex.), according to the manufacturer's protocol, and assessed for purity and integrity by spectroscopy and agarose gel electrophoresis.
Generation and amplification of G␣ s -cDNAs by reverse transcription-polymerase chain reaction (RT-PCR)
RT reaction was performed with 1 g total myometrial RNA, oligo(dT) [25] [26] [27] [28] [29] [30] containing the sites of alternative splicing associated with exon 3. PCR amplification and subcloning were accomplished by standard protocols, sequences were controlled by sequencing (Medigene, Martinsried, Germany).
RNase protection assay (RPA)
RPAs were performed with the RPA II kit (Ambion, Austin, Tex.) as described previously (19) . Each sample contained 3 g total RNA and 200,000 dpm 32 P-labeled cRNA. Dried gels were exposed on imaging plates (BAS-IP MP 2040 P; Fuji) for 18 -36 h and scanned by PhosphoImager (BAS 2000; Fuji). Spots were quantified using software TINA 2.0 (Raytest) and Zerodescan (CSP). Quantification in absolute values was performed as described (19) .
Statistical analysis
All values presented are arithmetic means Ϯ se. Statistical significance was estimated using Student's t test for unpaired observations. For AC assays and smoothelin expression, statistical significance was estimated using Mann-Whitney U test for unpaired nonparametric observations. A P value of less than 0.05 was considered significant.
RESULTS
5-Nucleotidase activity
5Ј-Nucleotidase activity was ϳ2.4-fold decreased in pregnant myometrial tissue ( Fig. 1 ; P vs. NP: 55Ϯ5 and 130Ϯ13 U/g membrane protein), most likely reflecting the expected reduction in sarcolem sarcoplasm relation in hypertrophied pregnant myometria.
Adenylyl cyclase activity
In pregnant myometria, basal AC activity was increased by ϳsevenfold (P vs. NP: 16.7Ϯ2.9 and 2.3Ϯ0.41 pmol⅐mg protein Ϫ1 ⅐min Ϫ1 ; Fig. 2 ). In membranes from P and NP, AC activity could be stimulated independent of G␣ s by MnCl 2 (5 mM) or dependent on G␣ s (forskolin 3 M; ref 20) by the GTP analog 5Ј-guanosine-␤␥-iminotriphosphate (GppNHp,10 M; Fig. 2 ) and, to a lesser extent, by GTP (100 M; Fig. 3 ). In general, the values obtained with either stimulus reflected the higher AC activity in pregnant myometria with similar interindividual variabilities. The ␤-adrenoreceptor agonist isoproterenol (10 M) did not further increase GTP-elevated AC activity in either NP or P (Fig. 3) .
␤-Adrenoreceptor density
Myometrial ␤-adrenoreceptors were quantified in saturation experiments (12.5-3000 nM) with 
G␣ s mRNA
An RNase protection assay with two different antisense [ 32 P]cRNA probes was designed that allows for quantification of the four known G␣ s mRNA splice variants (Fig. 4) . A 266 nt probe (G␣ s -cRNA-266) differentiated between the two large splice variants G␣ s -1 and G␣ s -2, whereas fragments of the short G␣ s -3 and G␣ s -4 (60ϩ63 and 60ϩ66 nt, respectively) were not distinguishable from a short fragment of G␣ s -1 (Fig. 5A) . A 276 nt probe (G␣ s -cRNA-276) detected G␣ s -4 as a single protected fragment of 199 nt (Fig. 4 and Fig. 5B) . G␣ s -1 mRNA was ϳ18-fold and 2.3-fold more abundant than G␣ s -2 and G␣ s -4, respectively. G␣ s -1-and G␣ s -2 mRNA levels were identical in NP (nϭ7-10) and P (nϭ19 -21), whereas the small G␣ s -4 mRNA was modestly increased in P (6.9Ϯ0.2 vs. 5.8Ϯ0.3 amol/g; Pϭ0.037; Fig. 5C ).
G␣ s -3 could not be directly detected in these assays. However, riboprobe G␣ s -cRNA-276 produced a 133 nt protected fragment that could derive from protection by either G␣ s -1-, G␣ s -2-, or G␣ s -3-mRNA. Since the ratio of (G␣ s -1 ϩ G␣ s -2 ϩ Figure 1 . Membrane marker 5Ј-nucleotidase activity was determined in crude membranes from nonpregnant (NP; nϭ9) and pregnant (P; nϭ9) myometria to equalize differences in membrane/sarcoplasm relation due to pregnancy-induced myometrial hypertrophy. *PϽ0.05 vs. nonpregnant. 
G␣ s protein
Immunoblotting with an antibody (3A-150) directed against the extreme carboxyl-terminal decapeptide of G␣ s detected two prominent bands with an apparent molecular mass of ϳ45 and 47 kDa in both NP and P. In addition, antiserum 3A-150 recognized two proteins with an apparent molecular mass of ϳ51 kDa and 59 kDa (Fig. 6A, lanes 1-4) . The 59 kDa protein was the most prominent signal in P, but was barely detectable in NP. In contrast, antibody K-20 directed against a more amino-terminal epitope in the G␣ s protein (AA 100 -119), recognized only the 45 kDa (G␣ s -short) and 47 kDa proteins (G␣ s -long; Fig. 6A, lanes 5-8) . When related to individual 5Ј-nucleotidase activity, their levels were identical in NP and P, regardless of the antibody used (Fig. 6B) . The identity of the various protein bands was further investigated by binding experiments with the photoreactive GTP analog [␥-32 P]-GTP-azido-anilide and subsequent immunoprecipitation with antibodies 3A-150 or K-20 and SDS-polyacrylamide gel electrophoresis (PAGE). This analysis revealed only two labeled G␣ s at 45 and 47 kDa in both NP and P (Fig. 7) and no labeling of higher molecular mass subtypes.
Identification and quantification of the 59 kDa protein recognized by antiserum 3A-150
Since a number of antisera that were all directed against the extreme carboxyl terminus of G␣ s (3A- 150, RM/1, C267) had similarly recognized the higher molecular weight proteins in pregnant myometrial tissue (9) , an EMBL database screen was performed for proteins with sequence homology with the carboxyl-terminal decapeptide RMHL-RQYELL of G␣ s . This analysis revealed that a recently described 59 kDa cytoskeletal glycoprotein, smoothelin (EMBL accession number: Z49989) shares a 71% homology in a carboxyl-terminal stretch of eight amino acids (Fig. 8A) . Accordingly, antiserum 3A-150 immunoprecipitated smoothelin as demonstrated by a single band of 59 kDa detected by a smoothelin antiserum (Fig. 8B, lane 2) . In contrast, immunoprecipitations without antiserum or with antiserum K-20 were negative for smoothelin (Fig. 8B,  lanes 1, 3) . In addition, the predominant 59 kDa band in membranes from P that was recognized by antiserum 3A-150 comigrated with the protein detected by the anti-smoothelin antibody (r f ϭ 0.46). Since antiserum 3A-150 had detected the 59 kDa protein at much higher levels in P (34.0Ϯ8.4) (nϭ6) vs. 3.3Ϯ1.1 AU (NP; nϭ7); Fig. 6A, lanes 1-4) , we quantified smoothelin levels in NP and P by immunoblotting (Fig. 9A) . Smoothelin levels were increased ϳ10-fold in pregnant myometria (P vs. NP: 11.1Ϯ0.3 and 1.1Ϯ0.1 AU; nϭ4; Fig. 9B ).
DISCUSSION
Several studies have attributed a major role to the modulation of AC activity in regulating quiescence and contractility during pregnancy (for references, see ref 1 ). An increase in cAMP formation induces relaxation of the uterus, a decrease favors contraction. Several prostanoids and catecholamines stimulate AC activity via stimulatory G-proteins, and changes of the latter have been proposed as important factors controlling uterine relaxation during pregnancy (9) . Studies in animals and humans revealed substantial species differences. In guinea pig, basal and GTP-dependent stimulation of AC activity was increased with unchanged forskolin stimulation in pregnant myometria (21, 22) . A study of human myometria found increased GppNHp, most likely enhanced G␣ s -dependent stimulation of AC in pregnant myometria, but an unchanged basal AC activity (9) . In contrast, our data predominantly point to an overall increase in AC activity in pregnant myometrium. Although we observed substantial interindividual variability, the increase in AC activity was clearly evident under every condition tested: AC activity in pregnant myometrium was ϳsevenfold higher. AC activity in the presence of MnCl 2 (no GTP present) was also significantly increased. Since MnCl 2 is believed to stimulate AC independent of G-proteins, these data argue for changes in the catalytic subunit of the AC itself.
We would like to offer three fundamental differences between our study and the previous work of Europe-Finner and co-workers (9) that may contribute to this obvious discrepancy. First, as outlined before, we related all measurements in membrane preparations to the plasma membrane marker 5Ј-nucleotidase. We consider this to be necessary because 5Ј-nucleotidase activity/mg protein was ϳ2.4-fold lower in membranes from pregnant myometria, which as we believe reflects dilution of the plasma membrane fraction due to hypertrophy during pregnancy. In crude membrane preparations, as used in the present and in the former study (9) , the increase in other particulate protein-containing material caused by the hypertrophy will reduce the fraction of plasma membranes. Moreover, the observed dilution factor correlates exactly with the hypertrophy factor determined by electrophysiological measurement of membrane capacity (M. Korth, personal communication). Second, in contrast to the previous studies, we determined AC activity in individual membrane preparations and not in membrane pools obtained from several patients. Taking the substantial interindividual differences in AC activity into account, such a pooling procedure may disguise differences otherwise detected. Third, the former study measured AC activity in the presence of high MgCl 2 (12 mM) compared to a medium concentration in our study (5 mM). AC activity is markedly stimulated by free Mg 2ϩ ions (23, 24) . This could theoretically obscure differences in 'basal' activity.
In accordance with Europe-Finner and co-workers (9), we detected a higher efficacy of GppNHp to stimulate AC in pregnant myometria (1.1-fold in NP vs. 2.1-fold in P). Similarly, relative stimulation of AC by forskolin was increased in pregnant myometrium (2.4-fold in NP vs. 4.8-fold in P). Because the effects of GppNHp and forskolin depend (partially) on G␣ s , these increases could be taken as an argument for the role of G␣ s . Thus, increased cAMP formation in pregnant myometria may be due to various reasons. Increased activity of the AC itself appears to be involved, but the input by G␣ s may be enhanced also.
We observed no stimulatory effect of isoproterenol on AC activity in either pregnant or nonpregnant myometria. These data, which are in apparent contrast to data reported from rat (25), correlate well with the low ␤-adrenoreceptor density in human myometrium. An earlier report indicated a density of 9.4 fmol/mg (26) . We found 5.8 and 6.2 fmol/mg protein in nonpregnant and pregnant myometria, respectively, which is in line with Engelhardt et al. (27) , who reported a density of ϳ6 fmol/mg. These authors also could not detect stimulation by isoproterenol (personal communication). The amount of ␤-adrenoreceptors in pregnant human myometrium is therefore 15-to 20-fold lower than that found in the rat (28) ; in contrast to the rat, their expression is apparently not up-regulated in human myometrium during pregnancy. We know, however, that in electrophysiological recordings of cAMP-mediated effects in smooth muscle cells of pregnant human myometrium, isoproterenol evokes moderate cAMPmediated effects (data not shown), proving coupling to AC stimulation. But due to their low expression, this effect appears to escape detection in the membrane AC assay. In any case, the low ␤-adrenoreceptor density in pregnant human myometrium together with their down-regulation during tocolytic therapy with ␤-adrenoreceptor agonists (27) may be one reason for the often unsatisfactory effectiveness of these drugs in the treatment of preterm labor (29) .
In animal models, there are several lines of evidence for changes in the myometrial expression of G-proteins during pregnancy. In the rat, G␣ i3 decreases significantly toward term of pregnancy, and G␣ i2 and G␤ increase at midgestation and return to normal levels at term (30) . In the same species, G␣ s increases at midgestation and decreases at term (4). In guinea pig, G␣ s is higher in nonpregnant uterus than in the pregnant uterus near term; the opposite changes occur with G␣ i and G␣ o , whereas G␣ q/11 is low in early pregnancy but increases near term (31) . In contrast, the expression of G␣ i subtypes and G␣ q/11 is not altered in humans during pregnancy (9, 32) . Furthermore, G␣ o subtypes are expressed in pregnant human myometria, but are absent in pregnant rat myometria (32) . Thus, caution must be taken in extrapolating these results to humans.
Immunoblot experiments on human myometrial membranes with RM/1, an antiserum raised against the extreme carboxyl terminus of G␣ s , showed that several proteins (45, 46, 47, 54, and 58 kDa) were expressed in pregnant myometria (8) . The 54 and 46 kDa proteins, which were barely detectable in nonpregnant samples, were the most prominent signals in pregnant myometria, but only the 45 and 47 kDa proteins were ADP-ribosylated by cholera toxin. Despite lacking this typical property of all G␣ s isoforms, including XL-G␣ s (33) , all proteins recognized by antiserum RM/1 were regarded as G␣ s isoforms, and thus a marked increase of G␣ s expression in the human uterus during pregnancy was reported. The results were confirmed with additional antisera (3A-150, C267), which were, however, raised against the same extreme carboxyl-terminal epitope of G␣ s (9) . Analysis of the four known mRNA splice variants of G␣ s 1-4 (16, 17, 34) revealed an increase in splice variants G␣ s -2 and G␣ s -4 by ϳ100%, but did not match the apparent increase in the large protein bands (35) .
In the present investigation, we designed an RNase protection assay that allowed quantification of G␣ s mRNA splice variants in absolute amounts. We found that G␣ s -1 (G␣ s -long without CAG) is the splice variant predominantly expressed in human myometria. In accordance with the data obtained by Europe-Finner et al. (34) , G␣ s -2 (G␣ s -long with CAG) showed a much weaker expression in myometrial tissue than G␣ s -1. G␣ s -4 (G␣ s -short with CAG) was expressed at about half of the amount of G␣ s -1, and G␣ s -3 mRNA levels were below the detection limit of the RPA. Apart from the small, but mathematically significant, increase in G␣ s -4, we detected no alterations in G␣ s -mRNA expression in pregnant myometria. Since G␣ s -4 encodes a small G␣ s protein, we conclude that the apparent increase in large G␣ s isoforms has no counterpart on the mRNA level.
There is often no quantitative correlation between mRNAs and the respective protein(s) translated (35) . In addition, apparently larger isoforms of G␣ s may arise from posttranslational modification, such as covalent linkage of fatty acids (e.g., palmitoylation) to G␣ s proteins. Nevertheless, all G␣ s isoforms should 1) be recognized by both antiserum 3A-150 (raised against the extreme carboxyl terminus of G␣ s ) and antiserum K-20 (raised against a more amino-terminal epitope in G␣ s that is unaffected by the known splicing mechanisms) and 2) should be labeled by the photoreactive GTP-analog [␥- 32 P]GTP-azido-anilide. Only the 45 and 47 kDa bands, which represent the ubiquitously expressed isoforms G␣ s -short and G␣ s -long, respectively (36 -38) , fulfilled these criteria. When referred to total membrane protein, levels of G␣ s 45 and 47 kDa were significantly lower in pregnant myometria. When related to the plasma membrane marker, 5Ј-nucleotidase activity (see above), no difference in the content of G␣ s 45 and 47 kDa between nonpregnant and pregnant myometria was observed. Taken together, we did not obtain evidence for up-regulation of G␣ s either on the mRNA or protein level.
The question arose as to the identity of the two additional strong signals in membranes from pregnant myometria that migrated in our gel system at 51 and 59 kDa. Taking into consideration that the electrophoretic mobility of proteins is altered in SDS-PAGE containing urea (39, 40) and that they were detected by antiserum 3A-150 in pregnant myometria in a pattern similar to that reported before for other antisera raised against the extreme carboxyl terminus of G␣ s , these proteins are most likely identical to the 46 and 54 kDa proteins described earlier (8, 9) . Through a database search for proteins with an epitope similarity with the carboxylterminal peptide of G␣ s , we found that a recently identified human cytoskeletal glycoprotein, smoothelin, exhibits a 71% homology in its carboxyl terminus. Smoothelin consists of 371 amino acids and has an apparent molecular mass of 59 kDa (14) . Immunohistochemistry of avian gizzard smooth muscle revealed codistribution of smoothelin with desmin and filamen and association with the actin cytoskeleton (41) . Smoothelin is highly specific for the contractile phenotype of smooth muscle. We obtained threefold evidence that smoothelin is indeed the 59 kDa protein recognized by the G␣ s antiserum 3A-150. 1) Using the monoclonal anti-smoothelin antibody R4A, we could show that in contrast to antiserum K-20, antiserum 3A-150 immunoprecipitated smoothelin. 2) In normal immunoblots, the 59 kDa band recognized by 3A-150 strictly comigrated with the single band recognized by the smoothelin antiserum R4A. 3) Smoothelin was found to be ϳ10-fold up-regulated during pregnancy, a value very similar to that obtained for the 59 kDa band recognized by 3A-150. In accordance with our data, several other cytoskeletal proteins are up-regulated in human myometrium during pregnancy, such as desmin (42) , ␥-actin, and myosin light chain (43) . Therefore, the data suggest that the elevated smoothelin expression accounts for the additional 59 kDa protein recognized by all antisera that are raised against the extreme carboxyl terminus of G␣ s in pregnant human myometria. The exclusive expression of smoothelin in smooth muscle and the fact that it has only recently been identified may explain why the problem with cross-reactivity of these antisera has not been observed before and why smoothelin has been misinterpreted as a large isoform of G␣ s . We did not yet find a correlate for the 51 kDa band also recognized by antiserum 3A-150, but it is reasonable to suggest that this protein is another, so far unknown protein that shares an epitope similarity with G␣ s .
Taken together, the present study showed AC activity to be markedly increased in pregnant human myometrium and confirmed alterations in G␣ s -dependent AC regulation. It refutes, however, the hypothesis that this is due to alterations in the expression (either quantity or pattern) of G␣ s protein isoforms . Instead, up-regulation of the cytoskeletal glycoprotein smoothelin was identified that, by epitope sharing, mimics up-regulation of the formerly described 56 -59 kDa [larger G␣ s isoforms]. It is likely that smoothelin is involved in myometrial hypertrophy, but unlikely that it relates to the increase in AC activity. The reasons for the latter remain unknown, but given that the largest difference was the overall increase in AC activity, our results point to alterations in the adenylyl cyclase (subtypes) itself. This would be in line with recent data showing that ␣ 2 -adrenergic agonists that normally inhibit AC via G i can actually stimulate adenylyl cyclase via G i -released ␤␥ subunits during pregnancy (25, 44).
